Louis Pasteur was a French biologist, microbiologist and chemist renowned for his discoveries of the principles of vaccination, microbial fermentation and pasteurization. He is remembered for his remarkable breakthroughs in the causes and prevention of diseases, and his discoveries have saved many lives ever since. He reduced mortality from puerperal fever, and created the first vaccines for rabies and anthrax.
Lap-Chee Tsui, GBM, OC, OOnt, JP, FRS, FRSC is a Chinese-born Canadian geneticist and served as the 14th Vice-Chancellor and President of the University of Hong Kong.
Pathophysiology – a convergence of pathology with physiology – is the study of the disordered physiological processes that cause, result from, or are otherwise associated with a disease or injury. Pathology is the medical discipline that describes conditions typically observed during a disease state, whereas physiology is the biological discipline that describes processes or mechanisms operating within an organism. Pathology describes the abnormal or undesired condition, whereas pathophysiology seeks to explain the functional changes that are occurring within an individual due to a disease or pathologic state.
Pierre Paul Émile Roux FRS was a French physician, bacteriologist and immunologist. Roux was one of the closest collaborators of Louis Pasteur (1822–1895), a co-founder of the Pasteur Institute, and responsible for the Institute's production of the anti-diphtheria serum, the first effective therapy for this disease.
Luc Antoine Montagnier is a French virologist and joint recipient, with Françoise Barré-Sinoussi and Harald zur Hausen, of the 2008 Nobel Prize in Physiology or Medicine for his discovery of the human immunodeficiency virus (HIV). He has worked as a researcher at the Pasteur Institute in Paris and as a full-time professor at Shanghai Jiao Tong University in China.
The Pasteur Institute is a French non-profit private foundation dedicated to the study of biology, micro-organisms, diseases, and vaccines. It is named after Louis Pasteur, who made some of the greatest breakthroughs in modern medicine at the time, including pasteurization and vaccines for anthrax and rabies. The institute was founded on June 4, 1887, and inaugurated on November 14, 1888.
Donald Pinkston "Don" Francis is an American epidemiologist who worked on the Ebola outbreak in Africa in the late 1970s, and as an HIV/AIDS researcher. He retired from the U.S. Public Health Service in 1992, after 21 years of service. He lives in San Francisco, California.
bioMérieux is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors.
Professor Joseph Sriyal Malik Peiris FRS, d'Honneur, was born on 10 November 1949 in Sri Lanka. He is long based in Hong Kong SAR, China, after having previously trained and worked in Sri Lanka and the UK. He is a renowned pathologist and virologist. Prof. Malik Peiris is most notable for being the first person to isolate SARS virus.
Robert Charles Gallo is an American biomedical researcher. He is best known for his role in the discovery of the human immunodeficiency virus (HIV) as the infectious agent responsible for acquired immune deficiency syndrome (AIDS) and in the development of the HIV blood test, and he has been a major contributor to subsequent HIV research.
Institut Mérieux is a French holding company owned by the Mérieux family from Lyon.
Françoise Barré-Sinoussi is a French virologist and Director of the Regulation of Retroviral Infections Division and Professor at the Institut Pasteur in Paris, France. Born in Paris, France, Barré-Sinoussi performed some of the fundamental work in the identification of the human immunodeficiency virus (HIV) as the cause of AIDS. In 2008, Barré-Sinoussi was awarded the Nobel Prize in Physiology or Medicine, together with her former mentor, Luc Montagnier, for their discovery of HIV. She mandatorily retired from active research on August 31, 2015 and fully retired by some time in 2017.
The Pasteur Institute of Lille is a research centre and member of the Pasteur Institute network. It includes 14 research units and 1,150 employees including 626 researchers located in Lille, France. There are also 300 employees located outside the Pasteur site. Its revenues are above €70 million. Several neuroscience start-up companies have emerged from the Pasteur Institute of Lille.
Arthur W. Nienhuis is an American physician who served as fourth director and CEO of St. Jude Children's Research Hospital from 1993 to 2004. Prior to joining St. Jude, Nienhuis was chief of the Clinical Hematology Branch and deputy clinical director at the National Institutes of Health's Heart, Lung and Blood Institute. His research interests and expertise in bone marrow transplant, gene therapy and genetic testing paved the way for many advances at St. Jude, including breakthroughs in sickle cell disease and other hematological disorders. Nienhuis also made significant achievements in the fields of cell therapy, HIV/AIDS research and inherited immunodeficiencies. Under his leadership, the hospital completed a $1 billion expansion, which included the addition of a Children's GMP, LLC facility. Additionally, Nienhuis oversaw the creation of the Departments of Developmental Neurobiology and Structural Biology.
Institut Pasteur Korea is an infectious disease-focused research institute located in Gyeonggi Province, Rep. of Korea. Its mission is to identify novel molecular targets and discover small molecules by utilizing its proprietary platforms to diagnose, treat and address serious unmet global public health needs.
The French Louis Pasteur (1822–1895) and German Robert Koch (1843–1910) are the two greatest figures in medical microbiology and in establishing acceptance of the germ theory of disease. In 1882, fueled by national rivalry and a language barrier, the tension between Pasteur and the younger Koch erupted into an acute conflict.
Stewart Thomas Cole FRS is a British microbiologist. He is the director general of the Pasteur Institute since January 2018.
Nancy Tang Chang, née Tang Nanshan, is a biochemist who cofounded Tanox in 1986 to address medical needs in the areas of allergy, asthma, inflammation and diseases affecting the human immune system. Tanox took an innovative approach in developing an asthma drug that focused on the allergy-related basis of asthma, Xolair. In June 2003, the U.S. Food and Drug Administration (FDA) approved Xolair, the first biotech product cleared for treating those with asthma related to allergies. Tanox was also active in the development of TNX-355, an antibody for the treatment of HIV/AIDS. In 2007, Tanox was sold to Genentech for $919 million. Dr. Chang grew Tanox from an idea to a substantial publicly traded company, doing innovative science. Following her success with Tanox, she has become an angel investor in health-care entrepreneurships and performs philanthropic work in community health-education projects.
Pierre Charneau is a French virologist and inventor and head of the Molecular Virology and Vaccinology Unit (VMV) at the Pasteur Institute and an acknowledged specialist of HIV, lentiviral gene transfer vectors and their medical applications. His discovery of the central DNA-flap structure in the HIV genome, and its role in viral entry into the nucleus of the infected cell, grounded the optimization of lentiviral vectors and paved the way to more than 20 years of development in gene therapy and vaccines based on this gene delivery technology. Charneau has published more than 100 research articles and holds 25 patents in the field of HIV and lentiviral vectors.
